Risk of incident cardiovascular disease among patients with gastrointestinal disorder: prospective cohort study of 340,862 individuals

Background and Aims The associations between gastrointestinal diseases (GIs) and cardiovascular disease (CVD) were unclear. We conducted a prospective cohort study to explore their associations. Methods This study included 340,862 individuals without baseline CVD from the UK Biobank cohort. Individuals with and without GIs were followed up until the ascertainment of incident CVDs, including coronary heart disease (CHD), cerebrovascular disease (CeVD), and peripheral artery disease (PAD). The diagnosis of diseases was confirmed with combination of the nationwide inpatient data, primary care data, and cancer registries. A multivariable Cox proportional hazard regression model was used to estimate the associations between GIs and the risk of incident CVD. Results During a median follow-up of 12.4 years, 28,787 incident CVD cases were diagnosed. Individuals with GIs had an elevated risk of CVD (hazard ratio 1.38; 95% confidence interval 1.35-1.42, P<0.001). Eleven out of fifteen GIs were associated with an increased risk of CVD after Bonferroni-correction, including cirrhosis, non-alcoholic fatty liver disease, gastritis and duodenitis, irritable bowel syndrome, gastroesophageal reflux disease, peptic ulcer, celiac disease, pancreatitis, diverticular disease, biliary disease, and appendicitis. The associations were stronger among women, individuals aged [≤] 60 years, and those with body mass index [≥] 25 kg/m2. Conclusions This large-scale prospective cohort study revealed the associations of GIs with an increased risk of incident CVD, in particular CHD and PAD. These findings support the reinforced secondary CVD prevention among patients with gastrointestinal disorders.

[1]  J. Ryu,et al.  Risk of cardiovascular disease and mortality in patients with diabetes and acute pancreatitis history: a nationwide cohort study , 2022, Scientific Reports.

[2]  R. Horst,et al.  Low-grade inflammation as mediator between diet and behavioral disinhibition: A UK Biobank study , 2022, Brain, Behavior, and Immunity.

[3]  Liangrong Zheng,et al.  A Mendelian Randomization Study to Assess the Genetic Liability of Gastroesophageal Reflux Disease for Cardiovascular Diseases and Risk Factors. , 2022, Human molecular genetics.

[4]  Li Jin,et al.  Dissecting causal relationships between nonalcoholic fatty liver disease proxied by chronically elevated alanine transaminase levels and 34 extrahepatic diseases. , 2022, Metabolism: clinical and experimental.

[5]  C. Stehouwer,et al.  Relationship between non-alcoholic fatty liver disease and coronary artery disease: A Mendelian randomization study. , 2022, Hepatology.

[6]  Sang-Man Jin,et al.  The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study , 2022, Cardiovascular Diabetology.

[7]  S. Larsson,et al.  Gut microbiota–derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis , 2022, The American journal of clinical nutrition.

[8]  Ta-Liang Chen,et al.  Risk of acute atherosclerotic cardiovascular disease in patients with acute and chronic pancreatitis , 2021, Scientific Reports.

[9]  M. Hill,et al.  Inflammatory bowel disease and cardiovascular diseases: a concise review , 2021, European heart journal open.

[10]  J. Ludvigsson,et al.  Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort , 2021, Gut.

[11]  A. Mortara,et al.  Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population , 2021, Frontiers in Endocrinology.

[12]  E. Rimm,et al.  History of Diverticulitis and Risk of Incident Cardiovascular Disease in Men: A Cohort Study , 2021, Digestive Diseases and Sciences.

[13]  Yuan-Lin Guo,et al.  Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease , 2021, Hepatology International.

[14]  A. Naaraayan,et al.  Atherosclerotic Cardiovascular Disease Prevalence Among Patients With Celiac Disease in the United States: An Observational Study. , 2021, Mayo Clinic proceedings.

[15]  E. Benjamin,et al.  Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study , 2020, Hepatology.

[16]  H. Kamel,et al.  Gastrointestinal Disorders and Risk of First-Ever Ischemic Stroke , 2020, Stroke.

[17]  L. Liaudet,et al.  Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications , 2020, Nature Reviews Cardiology.

[18]  S. Larsson,et al.  Effects of tumour necrosis factor on cardiovascular disease and cancer: A two-sample Mendelian randomization study , 2020, EBioMedicine.

[19]  S. Hazen,et al.  Gut Microbiota and Cardiovascular Disease , 2020, Circulation research.

[20]  A. Linneberg,et al.  Long-term Consequences of Undiagnosed Celiac Seropositivity. , 2020, The American journal of gastroenterology.

[21]  G. Andersen,et al.  The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions , 2020, EBioMedicine.

[22]  F. Bäckhed,et al.  Intestinal Microbiota in Cardiovascular Health and Disease: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[23]  Yuquan Wei,et al.  Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors , 2018, Oncotarget.

[24]  E. Loftus,et al.  Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[25]  B. Nordestgaard,et al.  Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals , 2018, European heart journal.

[26]  J. Richman,et al.  New-Onset Cardiovascular Morbidity in Older Adults With Stage I to III Colorectal Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Kyunga Kim,et al.  Associations between reflux esophagitis and the progression of coronary artery calcification: A cohort study , 2017, PloS one.

[28]  E. Horváth-Puhó,et al.  Mortality and cardiovascular diseases risk in patients with Barrett's oesophagus: a population‐based nationwide cohort study , 2017, Alimentary pharmacology & therapeutics.

[29]  J. Manson,et al.  Gallstones and Risk of Coronary Heart Disease: Prospective Analysis of 270 000 Men and Women From 3 US Cohorts and Meta-Analysis. , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[30]  Zhen Chen,et al.  A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy , 2016, Cancer.

[31]  L. Qi,et al.  Gallstone Disease and the Risk of Ischemic Heart Disease , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[32]  E. Horváth-Puhó,et al.  Diverticular disease is associated with increased risk of subsequent arterial and venous thromboembolic events. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[33]  Siddharth Singh,et al.  Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[34]  J. Windsor,et al.  Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis , 2013, Gut.

[35]  J. Burnett,et al.  A gut-heart connection in cardiometabolic regulation , 2013, Nature Medicine.

[36]  Liang-qiu Tang,et al.  Relationship Between Helicobacter pylori Infection and Serum Interleukin‐18 in Patients with Carotid Atherosclerosis , 2013, Helicobacter.

[37]  T. Shibasaki,et al.  GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure , 2013, Nature Medicine.

[38]  H. Brenner,et al.  Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study. , 2012, Atherosclerosis.

[39]  C. Brensinger,et al.  No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[40]  I. Janszky,et al.  Childhood appendectomy, tonsillectomy, and risk for premature acute myocardial infarction--a nationwide population-based cohort study. , 2011, European heart journal.

[41]  D. Mozaffarian,et al.  Components of a Cardioprotective Diet: New Insights , 2011, Circulation.

[42]  Herng‐Ching Lin,et al.  Reflux Esophagitis and the Risk of Stroke in Young Adults: A 1-Year Population-Based Follow-Up Study , 2010, Stroke.

[43]  K. Nägga,et al.  Homocysteine Levels in Chronic Gastritis and Other Conditions: Relations to Incident Cardiovascular Disease and Dementia , 2009, Digestive Diseases and Sciences.

[44]  T. Fahey,et al.  The association between coeliac disease and cardiovascular disease , 2007, Alimentary pharmacology & therapeutics.

[45]  C. Land,et al.  Coronary heart disease after radiotherapy for peptic ulcer disease. , 2005, International journal of radiation oncology, biology, physics.

[46]  M. Wallander,et al.  Is there any association between myocardial infarction, gastro‐oesophageal reflux disease and acid‐suppressing drugs? , 2003, Alimentary pharmacology & therapeutics.